Shanu Modi

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study”.

Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0855

N/A

2.2DataRank · unranked

68 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases

npj Breast Cancer(2022)10.1038/s41523-022-00404-2

N/A

0.996DataRank · unranked

31 citations

Kathryn Beal, Stefanie N. Linch, Kateri J. Spinelli, Micaela Rodine, Darragh Halpenny +12 more

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0407

N/A

0.954DataRank · unranked

578 citations

Marjorie G. Zauderer, Isabelle Rivière, Stephen B. Solomon, Valerie W. Rusch, Roisin E. O’Cearbhaill +25 more

Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation

Nature Communications(2024)10.1038/s41467-024-53178-5

N/A

0.677DataRank · unranked

27 citations

Seth McNutt, Chiranjeevi Pasala, Hieu Nguyen, Daniel T. Thornton, Sahil Sharma +27 more

Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation

Nature Communications(2023)10.1038/s41467-023-39241-7

N/A

0.574DataRank · unranked

45 citations

Chao Xu, Chander Singh Digwal, Suhasini Joshi, Yogita Patel, Anand Ramaian Santhaseela +26 more

Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05726-y

N/A

0.550DataRank · unranked

38 citations

Dulce M. Barrios, Victoria Blinder, Jacqueline Bromberg, Pamela Drullinsky, Samuel A. Funt +10 more

First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3704

N/A

0.524DataRank · unranked

32 citations

Christina Pressl, Nagavarakishore Pillarsetty, Milan Grkovski, Shanu Modi, Komal Jhaveri +18 more

Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis

npj Breast Cancer(2023)10.1038/s41523-023-00592-5

N/A

0.396DataRank · unranked

13 citations

Jolene M. Singh, Anne S. Reiner, Joshua Z. Drago, Shanu Modi, Andrew D. Seidman +3 more

HER2 persistence after treatment with T-DXd in breast and gastrointestinal cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1052

N/A

0.292DataRank · unranked

6 citations

Fresia Pareja, Komal Jhaveri, Elaine M. Walsh, Geoffrey Y. Ku, Steven B. Maron +7 more

Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07143-3

N/A

0.241DataRank · unranked

4 citations

Stephen W. Dusza, Elizabeth Quigley, Helen Haliasos, Alina Markova, Michael A. Marchetti +7 more

Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1063

N/A

0.241DataRank · unranked

4 citations

Diana G. Wang, Victoria Blinder, Jacqueline Bromberg, Pamela Drullinsky, Samuel A. Funt +10 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578.v1

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Data from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer

(2023)10.1158/1078-0432.c.6529761.v1

N/A

0DataRank · unranked

0 citations

Christina Pressl, Nagavarakishore Pillarsetty, Milan Grkovski, Shanu Modi, Komal Jhaveri +18 more

Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients

Research Square(2023)10.21203/rs.3.rs-2679676/v1

N/A

0DataRank · unranked

0 citations

Stephen W. Dusza, Elizabeth Quigley, Helen Haliasos, Alina Markova, Michael A. Marchetti +7 more

Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives

Nature Reviews Clinical Oncology(2024)10.1038/s41571-023-00849-9

N/A

0DataRank · unranked

106 citations

Sarat Chandarlapaty, Shanu Modi, Antonio Marra

Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone

Cell Reports(2020)10.1016/j.celrep.2020.107840

N/A

0DataRank · unranked

63 citations

Hardik J. Patel, Sahil Sharma, Adriana Corben, Tai Wang, Palak Panchal +21 more

Phosphorylation-Driven Epichaperome Assembly: A Critical Regulator of Cellular Adaptability and Proliferation

Research Square(2024)10.21203/rs.3.rs-4114038/v1

N/A

0DataRank · unranked

1 citations

Seth McNutt, Tanaya Roychowdhury, Chiranjeevi Pasala, Hieu Nguyen, Daniel Thorton +27 more

Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding

Cancer Discovery(2025)10.1158/2159-8290.cd-25-0647

N/A

0DataRank · unranked

21 citations

Avantika Gupta, Nicholas Mai, Sharanya Nag, Joshua Lau, Sukrit Singh +12 more

Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy

JACC CardioOncology(2025)10.1016/j.jaccao.2025.05.006

N/A

0DataRank · unranked

8 citations

Chau T. Dang, Chaya S. Moskowitz, Akriti Mishra Meza, Patricia DeFusco, Eric Oligino +11 more

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06669-2

N/A

0DataRank · unranked

17 citations

Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S. Ross, Pedram Razavi +17 more

Local Therapy for Isolated Central Nervous System Progression Among Patients Receiving Antibody-Drug Conjugate Therapy

Advances in Radiation Oncology(2025)10.1016/j.adro.2025.101714

N/A

0DataRank · unranked

0 citations

Jordan Eichholz, Zhigang Zhang, Nicolas Toumbacaris, Brandon S. Imber, Linda Chen +9 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more